| Name | Recombinant Human TREML2, Fc Chimera |
|---|---|
| Supplier | Creative Biomart |
| Catalog | TREML2-521H |
| Category | Protein |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | NSO cells |
| Tag/Conjugation | Fc Chimera |
| Purity | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Bioactivity | Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated human T cells.Human PBMC cultured for 72 hours with PHA were incubated for an additional 3 days in 96 well plates coated with anti-CD3 and recombinant human TREML2/Fc Chimera.The ED50 for this effect is typically 0.45 - 1.8 μg/mL.Optimal dilutions should be determined by each laboratory for each applications. |
| SwissProt/Accession | Q5T2D2 |
| Gene | TREML2 |
| Description | Recombinant Human TREML2 (Accession # CAI19909) was produced in Mouse myeloma cell line, NS0-derived. |
| Supplier Page | Shop |